Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.35 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.35 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.35 |
| ▸ | HTR1D | P28221 | 1/20 | 0.35 |
| ▸ | HTR1B | P28222 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | MPO | P05164 | 1/20 | 0.32 |
| ▸ | SLC5A1 | P13866 | 1/20 | 0.31 |
| ▸ | SLC5A2 | P31639 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24689235 | 0.74 | RXRA (0.38) | ADRA2AADRA2BADRA2CADRA1DHTR1D | |
| SCHEMBL23446347 | 0.72 | KDM4E (0.34) | — | |
| SCHEMBL348623 | 0.65 | TSHR (0.52) | ADRA2AADRA2BADRA2CADRA1DHTR1D | |
| SCHEMBL24701725 | 0.63 | — | — | |
| SCHEMBL3452699 | 0.62 | CALM1 (0.57) | ADRA2AADRA2BADRA2CADRA1DHTR1D | |
| SCHEMBL23445064 | 0.61 | — | — | |
| SCHEMBL11437755 | 0.60 | ACHE (0.44) | ADRA2AADRA2BADRA2CADRA1DHTR1D | |
| SCHEMBL10767432 | 0.59 | KCNH2 (0.40) | ADRA2AADRA2BADRA2CADRA1DHTR1D | |
| SCHEMBL6547963 | 0.58 | TSHR (0.71) | ADRA2AADRA2BADRA2CADRA1DHTR1D | |
| SCHEMBL9428929 | 0.58 | SIGMAR1 (0.46) | ADRA2AADRA2BADRA2CADRA1DHTR1D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11685751-B2 | Compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-11685751-B2 | Compound and organic light-emitting element comprising same | LG CHEM, LTD. (KR) | 2023-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11685751-B2 | Compound and organic light-emitting element comprising same | CRY1, CRY2, LEF1 | ADRA2A 3625/4885ADRA2B 4055/4885ADRA2C 4094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.